MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Kevin Ali
Kevin AliORGANON & CO

Kevin Ali

CEO at ORGANON & CO

Manager

Deal Bio

Total Deals4
Valued Deals4
Total Value£ 7.18 B
Avg. Deal Size£ 1.80 B

Market Context

Sort

05 Feb 2020|United States|Pharmaceuticals
Merck & Co (women’s Health, Trusted Legacy Brands, And Biosimilars Businesses)
Institutional Investors

Target: MERCK & CO (WOMEN’S HEALTH, TRUSTED LEGACY BRANDS, AND BIOSIMILARS BUSINESSES)

Bidder: INSTITUTIONAL INVESTORS

8 Service Providers

2 Target | 6 Vendor

20 Dealmakers

3 Target | 17 Vendor

£ 5.39 B

Value

30 Mar 2021|United States|Medical Equipment
Alydia Health
Organon & Co

Target: ALYDIA HEALTH

Bidder: ORGANON & CO

6 Service Providers

3 Target | 3 Bidder

15 Dealmakers

2 Target | 13 Bidder

£ 174 M

Value

11 Nov 2021|Finland|Pharmaceuticals
Forendo Pharma
Organon & Co

Target: FORENDO PHARMA

Bidder: ORGANON & CO

4 Service Providers

3 Target | 1 Bidder

15 Dealmakers

9 Target | 6 Bidder

£ 706 M

Value

18 Sep 2024|United States|Biotechnology
DERMAVANT
Organon & Co

Target: DERMAVANT

Bidder: ORGANON & CO

7 Service Providers

1 Target | 3 Bidder | 3 Vendor

53 Dealmakers

1 Target | 20 Bidder | 32 Vendor

£ 909 M

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite